Dr. Mustafa Sahin, MD
What this data tells you about Dr. Sahin
Dr. Mustafa Sahin is a hematology in Melbourne, FL, with 19 years in practice. Based on federal Medicare data, Dr. Sahin performed 66,334 Medicare services across 1,694 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sahin received a total of $532 from 11 pharmaceutical and/or device companies across 23 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sahin is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) | 17,250 | $1 | $3 |
| Pembrolizumab injection (Keytruda) | 11,400 | $43 | $108 |
| Anti-nausea injection (fosaprepitant) | 9,900 | $0 | $4 |
| Paclitaxel chemotherapy injection | 6,580 | $0 | $1 |
| Denosumab injection (Prolia/Xgeva) | 5,880 | $18 | $47 |
| Epoetin alfa injection (Retacrit) for anemia | 3,660 | $6 | $22 |
| Abatacept infusion (Orencia) | 2,750 | $31 | $99 |
| Immune globulin infusion (Gammagard) | 2,250 | $36 | $92 |
| Dexamethasone injection (steroid) | 1,516 | $0 | $0 |
| Anti-nausea injection (Aloxi/palonosetron) | 710 | $1 | $26 |
| Injection, fulvestrant, 25 mg | 580 | $7 | $154 |
| Injection, granisetron hydrochloride, 100 mcg | 520 | $0 | $4 |
| Anti-nausea injection (ondansetron/Zofran) | 336 | $0 | $0 |
| Administration of chemotherapy into vein, 1 hour or less | 331 | $97 | $253 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 313 | $22 | $56 |
| Drug injection, under skin or into muscle | 312 | $11 | $42 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 218 | $49 | $134 |
| Injection of additional new drug or substance into vein | 201 | $12 | $36 |
| Injection, carboplatin, 50 mg | 197 | $2 | $29 |
| Administration of chemotherapy into vein, each additional hour | 118 | $22 | $55 |
| Injection, diphenhydramine hcl, up to 50 mg | 113 | $1 | $3 |
| Infusion, normal saline solution , 1000 cc | 110 | $2 | $6 |
| Injection, zoledronic acid, 1 mg | 94 | $6 | $23 |
| Collection of blood sample from implanted device | 93 | $20 | $52 |
| Infusion into a vein for hydration, 31-60 minutes | 92 | $25 | $96 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 85 | $129 | $1,060 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 84 | $16 | $40 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 75 | $23 | $66 |
| Administration of additional new drug or substance into vein, 1 hour or less | 72 | $49 | $123 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 51 | $53 | $141 |
| New patient office visit, complex (60-74 min) | 51 | $171 | $442 |
| Infusion into a vein for hydration, each additional hour | 44 | $10 | $25 |
| New patient office visit (45-59 min) | 39 | $129 | $335 |
| Hospital follow-up visit, high complexity | 39 | $96 | $241 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 39 | $3 | $12 |
| Initial hospital admission, high complexity | 30 | $140 | $351 |
| Administration of additional new drug or substance into vein using push technique | 26 | $41 | $108 |
| Office visit, established patient, complex (40-54 min) | 26 | $143 | $357 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 26 | $1 | $5 |
| Hospital follow-up visit, moderate complexity | 25 | $59 | $160 |
| Transfusion of blood or blood products | 24 | $30 | $76 |
| Red blood cells, leukocytes reduced, each unit | 24 | $64 | $564 |
| Irrigation of implanted venous access drug delivery device | 19 | $20 | $49 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 18 | $14 | $39 |
| Office visit, established patient (30-39 min) | 13 | $102 | $255 |
Industry Payment Transparency
Open Payments through 2022 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2022)
Associated products mentioned in payments ›
Most payments (86%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2022 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Sahin is a mixed practice specialist, with moderate Medicare volume, and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Sahin experienced with iron infusion (injectafer)?
Does Dr. Sahin receive payments from pharmaceutical companies?
How do Dr. Sahin's costs compare to other hematologys in Melbourne?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology